Y-mAbs Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ARQT
Arcutis Biotherapeutics, Inc. |
$15.01 | $838.13 M | -2.59 | 296 | $59.61 M |
BCEL
Atreca, Inc. |
$0.09 | $3.66 M | -0.04 | 90 | $770,000 |
BDTX
Black Diamond Therapeutics, Inc. |
$2.23 | $291.95 M | -3.13 | 54 | $0 |
BLUE
bluebird bio, Inc. |
$8.49 | $174.43 M | -1.44 | 375 | $29.50 M |
CCCC
C4 Therapeutics, Inc. |
$3.95 | $320.64 M | -1.97 | 145 | $20.76 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.78 | $1.12 B | -5.11 | 174 | $0 |
ERAS
Erasca, Inc. |
$2.54 | $647.94 M | -2.83 | 126 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$30.74 | $1.65 B | -11.47 | 108 | $0 |
GBIO
Generation Bio Co. |
$1.20 | $216.88 M | -1.28 | 174 | $5.90 M |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
KRON
Kronos Bio, Inc. |
$0.96 | $44.62 M | -0.37 | 58 | $6.29 M |
LRMR
Larimar Therapeutics, Inc. |
$4.02 | $611.84 M | -9.99 | 42 | $0 |
MIRM
Mirum Pharmaceuticals, Inc. |
$41.50 | $1.18 B | -6.7 | 311 | $186.37 M |
MRSN
Mersana Therapeutics, Inc. |
$1.59 | $261.85 M | -1.91 | 123 | $36.86 M |
MRUS
Merus N.V. |
$41.87 | $3.50 B | -19.38 | 172 | $43.95 M |
PASG
Passage Bio, Inc. |
$0.67 | $73.04 M | -0.77 | 58 | $0 |
PCVX
Vaxcyte, Inc. |
$86.56 | $7.72 B | -16.54 | 254 | $0 |
RVMD
Revolution Medicines, Inc. |
$44.08 | $6.66 B | -10.51 | 490 | $11.58 M |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.08 | $1.66 B | -6.02 | 184 | $0 |
STRO
Sutro Biopharma, Inc. |
$1.87 | $303.46 M | -1.97 | 302 | $153.73 M |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
TVTX
Travere Therapeutics, Inc. |
$17.19 | $542.80 M | -1.32 | 380 | $145.24 M |
VECT
VectivBio Holding AG |
$16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.00 | $754.16 M | -3.26 | 124 | $0 |